Anthropic has released Claude Sonnet 5, a more powerful and cost-effective AI model capable of autonomous planning and tool use, matching performance of pricier models like Opus 4.8. It will be the default model for all subscription plans, priced competitively below OpenAI's GPT-5.5 and Google's Gemini 3.1 Pro. Sonnet 5 improves on reasoning, coding, and knowledge work, while also enhancing safety by reducing undesirable behaviors and better refusing malicious requests. This release confirms that agentic AI capabilities are now standard, shifting competition to cost and reliability rather than basic functionality.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
